Literature DB >> 10749917

Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.

M Reni, A J Ferreri, C Landoni, E Villa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10749917     DOI： 10.1093/jnci/92.7.575

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  18 in total

Review 1.  Diagnosis and treatment of primary central nervous system lymphoma.

Authors:  Igor T Gavrilovic; Lauren E Abrey
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

Review 2.  New approaches in primary central nervous system lymphoma.

Authors:  Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal:  Chin Clin Oncol       Date:  2015-03

3.  Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status.

Authors:  Keishi Makino; Hideo Nakamura; Taku-Ichiro Hide; Jun-Ichi Kuratsu
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

4.  Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report.

Authors:  Jaclyn J Renfrow; Alisha Detroye; Michael Chan; Stephen Tatter; Thomas Ellis; Kevin McMullen; Annette Johnson; Ryan Mott; Glenn J Lesser
Journal:  J Neurooncol       Date:  2012-01-17       Impact factor: 4.130

Review 5.  The Challenge of Primary Central Nervous System Lymphoma.

Authors:  Julia Carnevale; James L Rubenstein
Journal:  Hematol Oncol Clin North Am       Date:  2016-12       Impact factor: 3.722

6.  Case report: a patient with primary CNS lymphoma treated with temozolomide to complete response.

Authors:  Keith A Lerro; Jill Lacy
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

Review 7.  Primary central nervous system lymphoma.

Authors:  Igor T Gavrilovic; Lauren E Abrey
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

8.  Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program.

Authors:  Stephen T Keir; John M Maris; C Patrick Reynolds; Min H Kang; E Anders Kolb; Richard Gorlick; Richard Lock; Hernan Carol; Christopher L Morton; Jianrong Wu; Raushan T Kurmasheva; Peter J Houghton; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2013-01-17       Impact factor: 3.167

9.  Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.

Authors:  Antonio M P Omuro; Luc Taillandier; Olivier Chinot; Charlotte Carnin; Maryline Barrie; Khe Hoang-Xuan
Journal:  J Neurooncol       Date:  2007-09-21       Impact factor: 4.130

10.  How I treat CNS lymphomas.

Authors:  James L Rubenstein; Neel K Gupta; Gabriel N Mannis; Amanda K Lamarre; Patrick Treseler
Journal:  Blood       Date:  2013-08-20       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.